Amrita Therapeutics is in the vanguard of biopharmaceutical companies translating microbiome technology into practical tools to improve human health.
Amrita's lead programs include truncated, naturally occurring peptide therapies effective against colorectal, bladder, liver and breast cancer, the SMAR1 biomarker for precision medicine, and the Amrita Breast/Prostate Cancer Device (ABCD) to provide localized therapy to the tumor site for safer, more sustainable cancer therapy..
Amrita was co-founded by biotechnology trailblazer Ananda M. Chakrabarty, PhD, and international biopharmaceutical veteran Susan K. Finston, JD/MPP, who serves as CEO and Managing Director.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Outer Room, 11, Devi Park Co.op. Housing Soc., B/h. Lake View Appt.,, Vastrapur,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- amritatherapeutics.com
- Keywords
- oncology, bio-discovery, therapeutic medical devices, Peptide therapies: oncology, HIV, antibiotics, peptide / protein therapies from microorganisms.
- HQ
- Ahmedabad, Gujarat
Amrita Therapeutics Questions
Amrita Therapeutics's website is amritatherapeutics.com
Amrita Therapeutics's LinkedIn profile is https://www.linkedin.com/company/amrita-therapeutics-ltd-
Amrita Therapeutics has
3 employees.
View email and phone details for 3
employees at Amrita Therapeutics.
Amrita Therapeutics's industry is
Biotechnology Research
Amrita Therapeutics's top competitors are
Up Med Devices,
Arlens,
Lab Medica Systems Pvt. Ltd.,
Atom Surgical,
Pendulum Technologies,
B V Patel Pharmaceutical Education And Research Development Centre,
Unikal Consultants,
Trigone Pharma,
Phoenix Regenerative Consultants,
Avitr Farmica Pvt Ltd.
Amrita Therapeutics's categories are Biotechnology Research
Amrita Therapeutics's founding year is 2008
